You are here: Industry Insights > cancer

News List

DNAtrix, Valo Therapeutics Enter Strategic R&D Pact contractpharma
November 28, 2018
DNAtrix and Valo Therapeutics entered an exclusive R&D collaboration to develop enhanced vaccines using DNAtrix's clinical stage viruses and Valo's antigenic peptide technology.
Evelo, Merck Enter Clinical Trial Collaboration contractpharma
November 28, 2018
Evelo Biosciences has entered into a clinical trial collaboration agreement with Merck. The collaboration will evaluate EDP1503 in combination with KEYTRUDA® (pembrolizumab),
US approves first ever TRK inhibitor pharmatimes
November 28, 2018
Bayer and Loxo Oncology’s Vitrakvi has become the first ever TRK inhibitor to be approved in the US, having been cleared to treat advanced solid tumours harbouring an NTRK gene fusion.
Machavert Pharmaceuticals Unveils a New Bioactive Lipid Drug Candidate for Cancer Treatment pharmafocusasia
November 28, 2018
Machavert Pharmaceuticals, a drug development company focused on bioactive phospholipid therapeutics for the treatment of cancer......
NHS lags best performers in cancer care – report pharmaphorum
November 28, 2018
The performance of NHS cancer services in England is lagging behind those of comparable countries, according to a new report.
CBT, Bossan Enter Clinical Collaboration contractpharma
November 27, 2018
CBT Pharmaceuticals (CBT) and Zhejiang Bossan Pharmaceutical Co., Ltd (Bossan) have entered into a clinical collaboration and license agreement to develop their respective assets in combination with each other.
Edge Therapeutics & PDS Biotechnology to Merge contractpharma
November 27, 2018
Edge Therapeutics, Inc. and PDS Biotechnology Corporation announced that their respective boards of directors have approved a definitive merger agreement.
Anchiano Therapeutics Names CMO contractpharma
November 27, 2018
David Kerstein, M.D., has been named chief medical officer of Anchiano Therapeutics, a clinical-stage biopharma company focused on novel therapies to treat cancer.
Breast implants reveal problems in tracking device safety foxbusiness
November 27, 2018
To all the world, it looked like breast implants were safe. From 2008 to 2015, the U.S. Food and Drug Administration publicly reported 200 or .....
Most pharma firms doing little R&D for poorer patients pharmaphorum
November 22, 2018
A ranking of pharma companies developing new medicines for low- and middle-income countries has revealed that just five companies are responsible for almost two-thirds of projects.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 87 88 Next page